N Stuart
Overview
Explore the profile of N Stuart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
975
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hare J, Burdiak G, Merlini S, Chittenden J, Clayson T, Crilly A, et al.
Rev Sci Instrum
. 2021 Apr;
92(3):033521.
PMID: 33820051
We report on a recently developed laser-probing diagnostic, which allows direct measurements of ray-deflection angles in one axis while retaining imaging capabilities in the other axis. This allows us to...
2.
Hare J, Suttle L, Lebedev S, Loureiro N, Ciardi A, Burdiak G, et al.
Phys Rev Lett
. 2017 Mar;
118(8):085001.
PMID: 28282176
We present a detailed study of magnetic reconnection in a quasi-two-dimensional pulsed-power driven laboratory experiment. Oppositely directed magnetic fields (B=3 T), advected by supersonic, sub-Alfvénic carbon plasma flows (V_{in}=50 km/s),...
3.
Suttle L, Hare J, Lebedev S, Swadling G, Burdiak G, Ciardi A, et al.
Phys Rev Lett
. 2016 Jun;
116(22):225001.
PMID: 27314720
We present experiments characterizing the detailed structure of a current layer, generated by the collision of two counterstreaming, supersonic and magnetized aluminum plasma flows. The antiparallel magnetic fields advected by...
4.
Neal R, Tharmanathan P, France B, Din N, Cotton S, Fallon-Ferguson J, et al.
Br J Cancer
. 2015 Mar;
112 Suppl 1:S92-107.
PMID: 25734382
Background: It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there...
5.
Ford E, Jenkins V, Fallowfield L, Stuart N, Farewell D, Farewell V
Br J Cancer
. 2011 Apr;
104(10):1535-43.
PMID: 21487408
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited attitudes and practices of cancer clinicians towards clinical trials. Method: The 43-item Clinicians Attitudes to Clinical...
6.
Gagkas Z, Heal K, Nisbet T, Stuart N
Sci Total Environ
. 2010 Jan;
408(6):1235-44.
PMID: 20071010
Due to its potential adverse effects on freshwater acidification, risk assessments of the impacts of forest expansion on surface waters are required. The critical load methodology is the standard way...
7.
Gagkas Z, Heal K, Stuart N, Nisbet T
Environ Pollut
. 2007 Nov;
154(2):232-40.
PMID: 18022740
Streamwater was sampled at high flows from 14 catchments with different (0-78%) percentages of broadleaf woodland cover in acid-sensitive areas in the UK to investigate whether woodland cover affects streamwater...
8.
Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein
Davies M, Roberts G, Stuart N, Wakeman J
Br J Cancer
. 2007 Jun;
97(3):384-90.
PMID: 17595655
Acquisition of truncating mutations in the adenomatous polyposis coli (APC) protein underlies the progression of the majority of sporadic and familial colorectal cancers. As such, the localisation patterns and interacting...
9.
Coombes R, Kilburn L, Snowdon C, Paridaens R, Coleman R, Jones S, et al.
Lancet
. 2007 Feb;
369(9561):559-70.
PMID: 17307102
Background: Early improvements in disease-free survival have been noted when an aromatase inhibitor is given either instead of or sequentially after tamoxifen in postmenopausal women with oestrogen-receptor-positive early breast cancer....
10.
von Minckwitz G, Chernozemsky I, Sirakova L, Chilingirov P, Souchon R, Marschner N, et al.
Anticancer Drugs
. 2005 Aug;
16(8):871-7.
PMID: 16096436
Two i.v. regimens, bendamustine, methotrexate and 5-fluorouracil (BMF) and cyclophosphamide, methotrexate and 5-fluorouracil (CMF) were compared as first-line therapy in a randomized, open, multicenter phase III trial including 364 patients...